| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/30-1/150 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | Hulp1; NULP1; FKSG26; PRO2620; hKIAA1049 |
| WB Predicted band size | 77 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse |
| Immunogen | Fusion protein of human TCF25 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于TCF25抗体的3篇示例文献(内容基于研究领域常见方向，建议通过学术数据库核实具体信息)：
---
1. **文献名称**：*TCF25 promotes epithelial-mesenchymal transition in colorectal cancer via Wnt/β-catenin signaling*
**作者**：Li X, et al. (2020)
**摘要**：本研究通过免疫组化(使用TCF25抗体)和Western blot分析，发现TCF25在结直肠癌组织中高表达，并通过激活Wnt/β-catenin信号通路促进EMT，增强癌细胞侵袭转移能力。
2. **文献名称**：*The role of TCF25 as a novel biomarker in hepatocellular carcinoma progression*
**作者**：Zhang Y, et al. (2019)
**摘要**：利用TCF25抗体进行组织芯片分析，证实TCF25在肝癌中表达升高，且与患者预后不良相关。机制研究表明TCF25通过调控miR-34a促进肝癌细胞增殖。
3. **文献名称**：*TCF25 interacts with Smad4 to facilitate TGF-β-induced tumor metastasis*
**作者**：Wang H, et al. (2021)
**摘要**：通过免疫共沉淀(TCF25抗体)和荧光共定位实验，揭示了TCF25与Smad4的相互作用，协同促进TGF-β信号驱动的乳腺癌转移，为靶向治疗提供新思路。
---
**注意**：以上为模拟文献，实际引用请通过PubMed、Web of Science等平台以“TCF25 antibody”或“TCF25 cancer”等关键词检索最新研究。
**Background of TCF25 Antibody**
The TCF25 (Transcription Factor 25) antibody is a tool used to detect and study the TCF25 protein, a member of the transcription factor family involved in regulating gene expression. TCF25 is implicated in various cellular processes, including cell cycle progression, apoptosis, and epithelial-mesenchymal transition (EMT). Research has linked TCF25 to cancer biology, where its overexpression is associated with tumor progression, metastasis, and poor prognosis in malignancies such as hepatocellular carcinoma, gastric cancer, and colorectal cancer.
The TCF25 antibody enables researchers to investigate the protein's expression patterns, subcellular localization, and interactions in both normal and diseased tissues. It is commonly utilized in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). Validated antibodies ensure specificity and reliability, often confirmed through knockout controls or siRNA-mediated silencing.
Studies using TCF25 antibodies have revealed its role in modulating pathways like Wnt/β-catenin and TGF-β, which are critical in cancer development. Additionally, TCF25 may serve as a potential biomarker for diagnosis or therapeutic targeting. However, challenges remain in fully understanding its regulatory mechanisms and clinical relevance. Overall, the TCF25 antibody is a vital reagent for exploring the protein's functional contributions to disease and its potential applications in biomedical research.
×
